Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2015-10-31
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brazil Nuts Effects on Selenium Status and Cognitive Performance
NCT02121457
Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients
NCT03945526
The Effect of Intervention With Potassium and/ or Magnesium-enriched Salt on Neurological Performance of Stroke Patients
NCT02910427
Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue
NCT01554787
COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)
NCT06062277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
selenium
vial selenium (selenase 500 microgr ) 2000 microgram stat and 1000 microgram daily for 5 days
Selenium
4 vials selenase stat and 2 vials daily for 5 days
normal saline
40 cc normal saline stat and 20 cc daily for 5 days( in vials like selenase vial)
normal saline
Normal saline infusion like intervention group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Selenium
4 vials selenase stat and 2 vials daily for 5 days
normal saline
Normal saline infusion like intervention group
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ischemic stroke in Middle Cerebral Artery territory
3. Volume of stroke at list one third of MCA territory
4. written informed consent.
Exclusion Criteria
2. Severe renal failure( cr clearance under 50 ml/min or serum cr upper than 2
3. Severe hepatic failure( total bill upper than 2 or ALT/AST 5 time upper than normal limit)
4. Severe neurodegenerative disease such as severe dementia, alzheimer and Parkinson
5. Pregnancy or lactation
20 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mazandaran University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Athena Sharifi Razavi
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
athena sharifi razavi, MD
Role: STUDY_CHAIR
assistant professor in neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Athena Sharifi Razavi
Sari, Mazandaran, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1421
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.